<乌鸦传媒>Year in Review: Early Breast Cancer USPSTF screening recommendations, broader indication for ribociclib, OS win for pembrolizumab Nov 12, 2024
<乌鸦传媒>Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests VA analysis finds men with limited life expectancy still getting aggressive treatment Nov 11, 2024
<乌鸦传媒>Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control More IKCS news: Long-term survival benefit with nivolumab/ipilimumab, disease-slowing surgery Nov 11, 2024
<乌鸦传媒>U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain Health news and commentary gathered by 乌鸦传媒 staff Nov 11, 2024
<乌鸦传媒>Higher Risk of Kidney Cancer Recurrence After Ablative Therapy Low rate of recurrence with surgery or nonsurgical options, but data can inform decisions Nov 10, 2024
<乌鸦传媒>CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record Confirmed responses in one-fourth to one-third of patients with refractory disease Nov 09, 2024
<乌鸦传媒>What the Astronomical Rise in Incarceration Means for Women's Health Health disparities, such as high rates of cervical cancer, in this population deserve attention Nov 09, 2024
<乌鸦传媒>New CAR T-Cell Therapy Approved for Leukemia Obecabtagene autoleucel has no requirement for a REMS program Nov 08, 2024
<乌鸦传媒>FDA Panel Backs Cryoablation in Early Breast Cancer as Alternative to Surgery ProSense device would be indicated with adjuvant endocrine therapy for some low-risk patients Nov 08, 2024
<乌鸦传媒>Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission Nov 08, 2024 video
<乌鸦传媒>'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer News, features, and commentary about cancer-related issues Nov 08, 2024
<乌鸦传媒>Nurse's Death Tied to GLP-1 Drug; Research Monkey Jailbreak; Congressman Has Cancer Health news and commentary gathered by 乌鸦传媒 staff Nov 08, 2024
<乌鸦传媒>Prostate Cancer Treatment Associated With Long-Term Complications Researchers say inadequate understanding of risks may lead patients to regret treatment decisions Nov 07, 2024
<乌鸦传媒>Watch for Psoriasis After Cancer Immunotherapy, Study Says PD-1/PD-L1 inhibitors singled out for association Nov 07, 2024
<乌鸦传媒>How Trump's Win Affects Healthcare; Uptick in COVID; Pesticides and Prostate Cancer Health news and commentary gathered by 乌鸦传媒 staff Nov 06, 2024
<乌鸦传媒>Asymptomatic or Minimally Symptomatic Myelofibrosis Momentum grows for earlier intervention, including pre-fibrotic disease Nov 04, 2024
<乌鸦传媒>ACG Roundup: Young-Onset Barrett's Esophagus on the Rise Selected highlights from the 2024 American College of Gastroenterology annual meeting Nov 04, 2024
<乌鸦传媒>Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer News, features, and commentary about cancer-related issues Nov 01, 2024
<乌鸦传媒>Year in Review: Non-Small Cell Lung Cancer A look back at some of the newsworthy developments of 2024 Nov 01, 2024
<乌鸦传媒>Advancing Health in Africa Rob Breiman, MD, discusses his public health work on the continent Oct 31, 2024 video
<乌鸦传媒>AI Colonoscopies: More Benign Lesion Removals, Potentially Higher Costs At scale, the benefits of AI-assisted colonoscopy may not always outweigh the costs Oct 31, 2024
<乌鸦传媒>Early Smoking Cessation After Cancer Diagnosis Tied to Better Survival Largest survival benefit observed in patients who entered a cessation program within 6 months Oct 31, 2024
<乌鸦传媒>'Converging' Evidence of Link Between Air Pollution and Breast Cancer Large cohort study showed cancer risk increased with exposure to fine particulate matter Oct 30, 2024
<乌鸦传媒>Low-Volume Bowel Prep Matches Standard for Inpatient Colonoscopy Patients also found MoviPrep to be more tolerable and were more willing to repeat it Oct 29, 2024
<乌鸦传媒>Blood Test for CRC Screening Lags Behind Other Options in Cost-Effectiveness Study Fewer cancers, cancer deaths prevented; higher cost per quality-year saved Oct 28, 2024
<乌鸦传媒>Precision Medicine Approach Shows Promise for Anaplastic Thyroid Cancer Median OS as high as 43 months with mutation-guided targeted agents plus immunotherapy Oct 25, 2024
<乌鸦传媒>Algorithm May Be Able to Predict HCC Risk in Advanced Chronic Liver Disease Easy to apply, uses parameters commonly measured in outpatient and inpatient settings Oct 25, 2024
<乌鸦传媒>Personalized Breast Cancer Treatment; Insights Into HPV in Men; Exercise and Cancer News, features, and commentary about cancer-related issues Oct 25, 2024
<乌鸦传媒>A Moral Code: Ethical Dilemmas in Medicine Three physicians face crossroads in patient care Oct 25, 2024 podcast
<乌鸦传媒>We Don't Always Know What's 'Best' for Our Patients Grappling with the illusion of patient autonomy Oct 25, 2024 podcast
<乌鸦传媒>Medicaid Expansion Linked to Better Survival in Aggressive Breast Cancer Study also showed that patients were more likely to receive timely treatment Oct 24, 2024
<乌鸦传媒>Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer Three cycles could become the new standard for retinoblastoma, researchers say Oct 21, 2024
<乌鸦传媒>How Do Younger People Fare With Stool Tests for CRC Screening? Retrospective study answers questions raised in shift to screening at age 45 Oct 21, 2024
<乌鸦传媒>Novel Targeted Drug Approved for Stomach Cancers Zolbetuximab indicated alongside fluoropyrimidine- and platinum-containing chemotherapy Oct 18, 2024
<乌鸦传媒>Diet and Prostate Cancer; TTFields OK'd for NSCLC; Cancer Studies Retracted -- News, features, and commentary about cancer-related issues Oct 18, 2024
<乌鸦传媒>Drugmaker Pulls Trodelvy's Bladder Cancer Approval In confirmatory trial, antibody-drug conjugate failed to improve OS versus chemotherapy Oct 18, 2024
<乌鸦传媒>Hormonal IUDs Linked to Increased Breast Cancer Risk Absolute risk remains low, however Oct 17, 2024
<乌鸦传媒>Pop Star Falls to His Death; Trump the 'Father of IVF'? Columbia Doc's Retractions Health news and commentary gathered by 乌鸦传媒 staff Oct 17, 2024
<乌鸦传媒>Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto Oct 16, 2024
